Hexaware Acquires SMC Squared, a Leader in Building Global Capability Centers
Rolls Out GCC 2.0 Service Line to Unlock Long-term Value for Enterprises MUMBAI, India and LONDON and ISELIN, N.J., July 17, 2025 /PRNewswire/ — Hexaware Technologies (NSE: HEXT), a global provider of IT solutions and services, is pleased to welcome into its fold SMC Squared, a leader in building global capability centers (GCCs). The acquisition […]
Essity: Interim Report Quarter 2, 2025
Organic growth and sequentially higher margin in a weak economy STOCKHOLM, July 17, 2025 /PRNewswire/ — Quarter 2, 2025 Net sales decreased 6.6% to SEK 34,185m (36,617). Excl. currency translation effects, net sales increased SEK 699m. Organic sales growth amounted to 1.9%, of which volume accounted for 0.2% and price/mix 1.7% EBITA decreased 12% to […]
Essity: Interim Report Quarter 2, 2025
Organic growth and sequentially higher margin in a weak economy STOCKHOLM, July 17, 2025 /PRNewswire/ — Quarter 2, 2025 Net sales decreased 6.6% to SEK 34,185m (36,617). Excl. currency translation effects, net sales increased SEK 699m. Organic sales growth amounted to 1.9%, of which volume accounted for 0.2% and price/mix 1.7% EBITA decreased 12% to […]
Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results
Hansa secures directed cash share issue of approximately 232 MSEK/US $24.3M and restructures NovaQuest debt. As compared to prior year Q2 IDEFIRIX product sales increased 76%. LUND, Sweden, July 17, 2025 /PRNewswire/ — Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced its interim report for January-June 2025. Renée Aguiar-Lucander, CEO, Hansa Biopharma said, “In […]
Volvo Group – the second quarter 2025
GOTHENBURG, Sweden, July 17, 2025 /PRNewswire/ — “In a quarter characterized by a general stabilization of the European market and more of uncertainty and a wait and see mode among customers in North America, the Volvo Group’s net sales declined by 5% adjusted for currency movements and amounted to SEK 122.9 billion (140.2). Sales of […]
Volvo Cars reports Q2 2025 results, turnaround plan is fully on track
GOTHENBURG, Sweden, July 17, 2025 /PRNewswire/ — Q2 revenue was SEK 93.5 bn (SEK 101.5 bn in Q2 2024) Q2 EBIT included items affecting comparability of SEK 12.9 bn, consisting of an impairment of SEK 11.4 bn and restructuring charge of SEK 1.4 bn Q2 EBIT was SEK -10.0 bn (SEK 8.0 bn in Q2 2024) Q2 EBIT excluding […]
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam
YONGIN, South Korea, July 17, 2025 /PRNewswire/ — GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from the Drug Administration of Vietnam (DAV). Following domestic approval in 2020 and WHO Pre-Qualification (PQ) in 2023, GC Biopharma has been accelerating individual country registrations as part of […]
Automation Anywhere anuncia la disponibilidad de agentes en AWS Marketplace
– Automation Anywhere anuncia la disponibilidad de agentes en la nueva categoría de agentes y herramientas de IA de AWS Marketplace NUEVA YORK, 17 de julio de 2025 /PRNewswire/ — En la Cumbre de AWS de Nueva York, Automation Anywhere, líder en automatización de procesos agénticos (APA), anunció hoy la disponibilidad de agentes de IA […]
Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results
Hansa secures directed cash share issue of approximately 232 MSEK/US $24.3M and restructures NovaQuest debt. As compared to prior year Q2 IDEFIRIX product sales increased 76%. LUND, Sweden, July 17, 2025 /PRNewswire/ — Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced its interim report for January-June 2025. Renée Aguiar-Lucander, CEO, Hansa Biopharma said, “In […]
EQT AB (publ) Half-year Report 2025
STOCKHOLM, July 17, 2025 /PRNewswire/ — Strong momentum in a volatile market environment “Following a difficult start to the year, global markets have regained strength – yet the outlook remains uncertain. Against this backdrop, EQT continues to deliver across all fronts: performance, exits and fundraising. EQT’s execution during the first half of 2025 sets us […]